Peter A Noertersheuser
Overview
Explore the profile of Peter A Noertersheuser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
La Via W, Notario G, Yu X, Sharma S, Noertersheuser P, Robbie G
Pulm Pharmacol Ther
. 2013 Mar;
26(6):666-71.
PMID: 23523663
Recent guidelines in British Columbia, Canada have suggested that the use of a maximum of 3 monthly doses of palivizumab 15 mg/kg intramuscularly for RSV immunoprophylaxis of high risk infants...
2.
Noertersheuser P, Pradhan R, Klein C, Williams L, Palaparthy R, Garimella T, et al.
J Clin Pharmacol
. 2011 Sep;
52(8):1162-73.
PMID: 21940716
Paricalcitol injection and capsules are approved for the prevention and treatment of secondary hyperparathyroidism. Exposure-response analyses were performed to describe paricalcitol pharmacokinetics and the relationship to clinical responses (intact parathyroid...
3.
Weisman M, Moreland L, Furst D, Weinblatt M, Keystone E, Paulus H, et al.
Clin Ther
. 2003 Jul;
25(6):1700-21.
PMID: 12860493
Background: Because traditional therapies for rheumatoid arthritis (RA) such as methotrexate (MTX) do not produce an adequate response in many patients, newer therapies that block the proinflammatory cytokine tumor necrosis...